Previous Close | 0.5099 |
Open | 0.5000 |
Bid | 0.5080 x 900 |
Ask | 0.5100 x 1400 |
Day's Range | 0.5000 - 0.5388 |
52 Week Range | 0.2650 - 1.3000 |
Volume | |
Avg. Volume | 303,769 |
Market Cap | 35.972M |
Beta (5Y Monthly) | 1.04 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2680 |
Earnings Date | Aug 03, 2022 - Aug 08, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.80 |
Subscribe to Yahoo Finance Plus to view Fair Value for ECOR
ROCKAWAY, N.J., June 23, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has received approval from the Nasdaq Stock Market (“Nasdaq”) to transfer the listing of its common stock from the Nasdaq Global Select Market to the Nasdaq Capital Market. The Company's common stock will continue to be traded under the symbol "ECOR" and trading of its common stock will be unaffected by this transfer. This
ROCKAWAY, N.J., May 24, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the gammaCore Sapphire™ non-invasive vagus nerve stimulator (nVNS) will be available for purchase through many of the more than 130 National Spine and Pain Centers (NSPC) affiliated locations across the United States for patients suffering from pain associated with different forms of primary headache. “National Spine and Pain Center’s mission
ROCKAWAY, N.J., May 18, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger, will be presenting at the H.C. Wainwright Global Investment Conference and LD Micro Invitational Conference. H.C. Wainwright Global Investment ConferenceDate: Tuesday, May 24, 2022 Time: 7:00 AM EDTWebcast: H.C. Wainwright WebcastLD Micro Invitational ConferenceDate: Tuesday, June 7, 2022T